Sustained complete remission of refractory enteropathy-type T-cell lymphoma following reduced-intensity unrelated cord blood transplantation [1]

Bone Marrow Transplantation

Volumn 40, Issue 9, 2007, Pages 905-906

  Chonabayashi, K ^a   Kondo, T ^a   Tanaka, Y ^a   Ichinohe, T ^a   Ishikawa, T ^a   Uchiyama, T ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MELPHALAN; PREDNISONE; TACROLIMUS; VINCRISTINE;

ABDOMINAL PAIN; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CHIMERA; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CORD BLOOD STEM CELL TRANSPLANTATION; ENTEROPATHY TYPE T CELL LYMPHOMA; FEMALE; GASTROINTESTINAL ENDOSCOPY; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; LETTER; MULTIPLE CYCLE TREATMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; T CELL LYMPHOMA; WEIGHT REDUCTION; WHOLE BODY RADIATION;

CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; HUMANS; INTESTINAL NEOPLASMS; LYMPHOMA, T-CELL, PERIPHERAL; MIDDLE AGED; REMISSION INDUCTION; SALVAGE THERAPY;

EID: 35648998463     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705828     Document Type: Letter

References (8)

1. Gale J, Simmonds PD, Mead GM, Sweetenham JW, Wright DH. Enteropathy-type intestinal T-cell lymphoma: Clinical features and treatment of 31 patients in a single center. J Clin Oncol 2000; 18: 795-803.
2. Wilson WH, Grossbard ML, Pittaluga S, Cole, D, Pearson D, Drbohlav N et al. Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: A pharmacodynamic approach with high efficacy. Blood 2002; 99: 2685-2693.
3. Moskowitz CH, Bertino JR, Glassman JR, Hedrick EE, Hunte S, Coady-Lyons N et al. Ifosfamide, carboplatin, and etoposide: A highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma. J Clin Oncol 1999; 17: 3776-3785.
4. Majhail NS, Burns LJ. Hematopoietic stem cell transplantation in the treatment of peripheral T-cell lymphomas. Curr. Hematol Rep 2005; 4: 252-259.
5. Sakai R, Fujisawa S, Fujimaki K, Kanamori H, Ishigatsubo Y. Long-term remission in a patient with hepatosplenic gamma-delta T cell lymphoma after cord blood stem cell transplantation following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2006; 37: 537-538.
6. Rodriguez J, Munsell M, Yazji S, Hagemeister FB, Younes A, Andersson B et al. Impact of high-dose chemotherapy on peripheral T-cell lymphomas. J Clin Oncol 2001; 19: 3766-3770.
7. Corradini P, Dodero A, Zallio F, Caracciolo D, Casini M, Bregni M et al. Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells. J Clin Oncol 2004; 22: 2172-2176.
8. Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, Leitman S et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 2000; 343: 750-758.